Risk Stocks To Buy 2017 - High

: A top performer in the S&P 500 with a 132% gain . High risk stemmed from a major corporate overhaul, where the company shed clean energy assets and cut costs under pressure from activist investors.

: Stocks like Freeport-McMoRan (FCX) and Cameco (CCJ) were considered high-risk due to volatile commodity prices. FCX, in particular, was viewed as a speculative "survival" play as it wrestled with high debt levels relative to cash flow. high risk stocks to buy 2017

: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. : A top performer in the S&P 500 with a 132% gain

: Another biotech leader, Nektar returned 387% following positive news regarding its immuno-oncology and painkiller treatments. FCX, in particular, was viewed as a speculative

: This biotechnology firm was a standout, posting a 426% return in 2017. Its growth was driven by positive clinical trial results for its cholesterol-reducing drug candidate.

Success in 2017 often depended on identifying specific catalysts within high-risk industries:

: Expectations of tax cuts and increased infrastructure support under the new U.S. administration provided a tailwind for industrial and homebuilding stocks like Boeing (BA) and D.R. Horton (DHI) .